-
1 Comment
Zhejiang Shouxiangu Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 1.0% below its 200 day moving average.
From a valuation standpoint, the stock is 12.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd's total revenue sank by 22.3% to $158M since the same quarter in the previous year.
Its net income has dropped by 63.1% to $25M since the same quarter in the previous year.
Finally, its free cash flow fell by 5.7% to $60M since the same quarter in the previous year.
Based on the above factors, Zhejiang Shouxiangu Pharmaceutical Co., Ltd gets an overall score of 1/5.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and traditional Chinese medicines under the Shouxiangu brand name. It is also involved in the wholesale and retail; technology research and development; and real estate business. The company was founded in 1909 and is headquartered in Jinhua, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603896.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
